85 related articles for article (PubMed ID: 21858496)
1. Analysis of doxorubicin uptake in single human leukemia K562 cells using capillary electrophoresis coupled with laser-induced fluorescence detection.
Deng B; Wang Z; Song J; Xiao Y; Chen D; Huang J
Anal Bioanal Chem; 2011 Oct; 401(7):2143-52. PubMed ID: 21858496
[TBL] [Abstract][Full Text] [Related]
2. Quantitative study of cellular heterogeneity in doxorubicin uptake and its pharmacological effect on cancer cells.
Deng B; Wang ZM; Zhou ZH; Liu YM; Yang XL; Song J; Xiao YX
Biomed Chromatogr; 2014 Oct; 28(10):1393-401. PubMed ID: 24687250
[TBL] [Abstract][Full Text] [Related]
3. Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.
Zheng Z; Aojula H; Clarke D
J Drug Target; 2010 Jul; 18(6):477-87. PubMed ID: 20088680
[TBL] [Abstract][Full Text] [Related]
4. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.
Szwed M; Matusiak A; Laroche-Clary A; Robert J; Marszalek I; Jozwiak Z
Toxicol In Vitro; 2014 Mar; 28(2):187-97. PubMed ID: 24055890
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines.
Szwed M; Laroche-Clary A; Robert J; Jozwiak Z
Chem Biol Interact; 2014 Sep; 220():140-8. PubMed ID: 24998637
[TBL] [Abstract][Full Text] [Related]
6. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
[TBL] [Abstract][Full Text] [Related]
7. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
8. Selective determination of the doxorubicin content of individual acidic organelles in impure subcellular fractions.
Chen Y; Walsh RJ; Arriaga EA
Anal Chem; 2005 Apr; 77(8):2281-7. PubMed ID: 15828758
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous analysis of liposomal doxorubicin and doxorubicin using capillary electrophoresis and laser induced fluorescence.
Kim HS; Wainer IW
J Pharm Biomed Anal; 2010 Jul; 52(3):372-6. PubMed ID: 19625153
[TBL] [Abstract][Full Text] [Related]
10. Genotoxic effect of doxorubicin-transferrin conjugate on human leukemia cells.
Szwed M; Jozwiak Z
Mutat Res Genet Toxicol Environ Mutagen; 2014 Sep; 771():53-63. PubMed ID: 25308442
[TBL] [Abstract][Full Text] [Related]
11. Distribution of zeptomole-abundant doxorubicin metabolites in subcellular fractions by capillary electrophoresis with laser-induced fluorescence detection.
Anderson AB; Ciriacks CM; Fuller KM; Arriaga EA
Anal Chem; 2003 Jan; 75(1):8-15. PubMed ID: 12530812
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.
Li R; Wu R; Zhao L; Wu M; Yang L; Zou H
ACS Nano; 2010 Mar; 4(3):1399-408. PubMed ID: 20148593
[TBL] [Abstract][Full Text] [Related]
13. Monitoring the subcellular localization of doxorubicin in CHO-K1 using MEKC-LIF: liposomal carrier for enhanced drug delivery.
Ho JA; Fan NC; Jou AF; Wu LC; Sun TP
Talanta; 2012 Sep; 99():683-8. PubMed ID: 22967611
[TBL] [Abstract][Full Text] [Related]
14. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
[TBL] [Abstract][Full Text] [Related]
15. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
Shen J; Zhang W; Wu J; Zhu Y
Int J Hyperthermia; 2008 Mar; 24(2):151-9. PubMed ID: 18283591
[TBL] [Abstract][Full Text] [Related]
16. Analysis of doxorubicin distribution in MCF-7 cells treated with drug-loaded nanoparticles by combination of two fluorescence-based techniques, confocal spectral imaging and capillary electrophoresis.
Gautier J; Munnier E; Soucé M; Chourpa I; Douziech Eyrolles L
Anal Bioanal Chem; 2015 May; 407(12):3425-35. PubMed ID: 25749791
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
[TBL] [Abstract][Full Text] [Related]
18. [Small interfering RNA targeting STAT3 enhances antitumor activity of doxorubicin].
Wang TX; Wang YY; Zhang ZQ
Yao Xue Xue Bao; 2013 Jan; 48(1):52-8. PubMed ID: 23600141
[TBL] [Abstract][Full Text] [Related]
19. Improving detection in capillary electrophoresis with laser induced fluorescence via a bubble cell capillary and laser power adjustment.
Rodat A; Gavard P; Couderc F
Biomed Chromatogr; 2009 Jan; 23(1):42-7. PubMed ID: 18661480
[TBL] [Abstract][Full Text] [Related]
20. Development of human leukemia U-937 cell sublines resistant to doxorubicin: induction of differentiation and altered sensitivities to topoisomerase-directed drugs.
Pantazis P; Dejesus A; Early J; Rodriguez R; Chatterjee D; Han Z; Wyche J; Giovanella B
Anticancer Res; 1995; 15(5B):1873-81. PubMed ID: 8572572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
